Hyperthyroidism
Conditions
Brief summary
This randomized controlled study aims to investigate the effects of using a mobile app that integrates with wearable devices to monitor heart rate, check self-reported symptoms, provide disease-related information, and set medication reminders for patients with thyrotoxicosis. The study intends to evaluate how the use of the app affects disease progression, quality of life, and health-related behaviors associated with the disease.
Interventions
OTHERUsing a mobile app that integrates with wearable devices
Using a mobile app that integrates with wearable devices to monitor heart rate, check self-reported symptoms, provide disease-related information, and set medication reminders for patients with thyrotoxicosis.
Sponsors
THYROSCOPE INC.
Seoul National University Bundang Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subjects who have been newly diagnosed or are currently undergoing treatment for thyrotoxicosis at Bundang Seoul National University Hospital. * Subjects must be able to use the smartphone app required for the use of wearable devices and their integration.
Exclusion criteria
* Subjects who have constraints on normal activity due to diseases other than thyroid dysfunction. * Subjects who are currently taking medication that affects heart rate. * Subjects with heart conditions such as arrhythmia that affect heart rate. * Subjects who cannot undergo antithyroid drug treatment and require surgery or radioactive iodine therapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Scores of quality of life assessed by SF-36 survey | baseline (at enrollment) | Scores of quality of life assessed by SF-36 survey |
| antithyroidal drug compliance | 6 weeks after baseline | Medication adherence assessed by directly counting the remaining pills after taking the prescribed medication. |
| Knowledge about hyperthyroidism | 14 weeks after baseline | A score measured through a test designed to assess the knowledge level about Graves' disease |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| free T4 | baseline | serum free T4 concentration |
| free T3 | baseline | serum free T3 concentration |
| TSH | baseline | serum free TSH concentration |
Countries
South Korea
Contacts
Primary ContactJae Hoon Moon, MD
Outcome results
None listed